scorecardresearch
Add as a preferred source on Google
Saturday, January 24, 2026
TopicGeneric drugs

Topic: Generic drugs

How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the US

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, with chunk of their earnings hinging on exports to the country.

South Eastern Coalfields Limited opens fourth AMRIT Pharmacy in Bilaspur

Launched in 2015, the AMRIT pharmacies, a flagship initiative of the Ministry of Health and Family Welfare, offer a broad selection of generic and life-saving branded drugs, implants, and surgical supplies at heavily discounted prices.

Alliance of India’s 26 top drugmakers opposes generic drug substitution at Janaushadhi Kendras

Leading drugmakers express apprehension over CDSCO’s proposal to permit generic alternatives for key medications, emphasizing the risk of compromised drug quality.

24 mega-seller drugs set to lose patents in US, big opportunity for Indian drugmakers — govt report

Patent expiry would mean that drugmakers will be able to launch generic versions of the blockbuster drugs, which are typically priced up to 90 percent lower than their innovator drug.

Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...

Kerala doctors & researchers plan India’s 1st private drug quality assessment drive

Project follows outcry over NMC rule, now on hold, asking medical practitioners to prescribe generics or face penalty. Dr Cyriac Abby Philips or ‘@TheLiverDoc’ part of project.

Prescribe generics or face penalty? Govt asks NMC to modify controversial rule for doctors

Rule part of Registered Medical Practitioner (Professional Conduct) Regulations, 2023. Opponents include Indian Medical Association, but some see it as a move in the right direction.

Drugs regulator to probe ‘faulty’ optical lens by Swiss-American firm Alcon

The Central Drugs Standard Control Organisation has formed an inquiry committee following a complaint by ophthalmologist and ex-parliamentarian Dr Vikas Mahatme.

Amid FTA talks, top pharma firms urge govt not to amend patents law, warn of impact on cheap meds

India in trade talks with US, UK and EU. Pharma companies say 'provision for patent holders to extend life of patent on medicine beyond 20 yrs will delay entry of generic medicine'.

Proposal to regulate prices of non-essential drugs on hold, RSS affiliate was among opponents

Central govt had proposed to apply trade margin rationalisation (TMR) approach to regulate prices of non-scheduled drugs, which would have resulted in capping trade margins.

On Camera

Controversial dog-walker IAS Sanjeev Khirwar is back in Delhi. What happened to his wife?

In 2022, athletes claimed they were asked to wind up training early at Thyagraj Stadium so that the IAS couple could walk their dog. Then came the memes and public outrage.

IndiGo profit plunges 78% as Dec meltdown with 3k flight cancellations takes a toll

Net income for InterGlobe Aviation Ltd slipped 78 percent to Rs 5.5 billion for the three months ended Dec 31 compared with the year-ago period.

Rafale saga: 25 yrs of detours, deadlocks & political hesitation. Now IAF getting what it always wanted

Instead of buying more Mirages outright in early 2000s, the requirement was tweaked in favour of a medium-weight, multi-role fighter with Mirage-like performance. 

Pakistan se azaadi. Grow up India, stop giving it prime real estate in your psyche

Pakistan not only has zero chance of catching up with India in most areas, but will inevitably see the gap rising. Its leaders will offer its people the same snake oil in different bottles.